Betapace
Product Images NDC 70515-109

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Betapace (NDC 70515-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Covis Pharma Us, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Structural Formula (Image 02)

FDA Label Image

Figure 2 (Image 03)

FDA Label Image

Figure 3 (Image 04)

FDA Label Image

Covis Logo (Image 05)

FDA Label Image

Principal Display Panel (80 mg Betapace)

FDA Label Image

Principal Display Panel (120 mg Betapace)

This appears to be a description of a medication called Chablet, indicated by the NDC number 70515-109-10. Each package contains 100 tablets with 120 mg of an active ingredient called "Fa" that may be misspelled and not clearly identifiable. The tablets likely contain hydrochloride and may be from a medication called Betapace®. The package may include a insert with additional information. The medication was likely manufactured in Spain and should be stored at a temperature of 15-30°C (59-86°F). The medication should be dispensed in a well-closed container and may have specific requirements for storage temperature.*

FDA Label Image

Principal Display Panel (160 mg Betapace)

This is a medication description for Semazc (sotalol HCI) produced by Covis Pharma. The medication is available in tablet form with 100 tablets per container. Dosage information is available on the package. It is recommended to store the medication in a well-closed container between 59-86°F. The medication is made in Spain and the container is to be dispensed with the code ACD039160 210A0f.*

FDA Label Image

Principal Display Panel (80 mg Betapace AF)

Each tablet contains 80 mg of sotalol hydrochloride. The recommended dosage should be followed as instructed by your physician. There is a package insert available for more information. The tablets should be stored at a controlled room temperature between 15-30°C (59-86°F). The NDC number for the 60 tablet unit is 70515-115-06, and the product is made in Spain by Pharma Zug.*

FDA Label Image

Principal Display Panel (120 mg Betapace AF)

Each tablet of this medication contains 120mg of sotalol hydrochloride. The dosage for this medication should be taken as prescribed by a physician. The package insert should be consulted for more information. The medication should be stored at room temperature 25°C (TT°F) and excursions are permitted to 15-30°C (59-86°F). The medication comes in a pack of 60 tablets and is made in Spain by Covis Pharma. NDC 70515-119-06 is the product code.*

FDA Label Image

Principal Display Panel (160 mg Betapace AF)

This is a description of a medication in tablet form. The medication is sotalol hydrochloride, and each tablet contains 160 mg of the medication. The dosage should be taken as prescribed by a physician, with a package insert available for more information. The tablets are sold in a patient pack containing 60 tablets per unit. The medication should be stored at a temperature not exceeding 25°C with excursions permitted to 15-30°C. The medication is produced by Covis Pharma and is intended for use in treating an underlying medical condition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.